You are here

Article Text

Article menu

This article has a correction. Please see:

Download PDFPDF
Review
Paroxysmal nocturnal haemoglobinuria: Nature's gene therapy?
  1. R J Johnson1,
  2. P Hillmen2
  1. 1Department of Haematology, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham B9 5SS, UK
  2. 2Haematological Malignancy Diagnostic Service, The General Infirmary at Leeds, Great George Street, Leeds LS1 3EX, UK
  1. Correspondence to:
 Dr R J Johnson, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham B9 5SS, UK;
 johnsonr{at}heartsol.wmids.nhs.uk

Abstract

The development of paroxysmal nocturnal haemoglobinuria (PNH) requires two coincident factors: somatic mutation of the PIG-A gene in one or more haemopoietic stem cells and an abnormal, hypoplastic bone marrow environment. When both of these conditions are met, the fledgling PNH clone may flourish. This review will discuss the pathophysiology of this disease, which has recently been elucidated in some detail.

  • paroxysmal nocturnal haemoglobinuria
  • PIG-A gene
  • aplastic anaemia
  • AA, aplastic anaemia
  • ER, endoplasmic reticulum
  • GPI, glycosyl phosphatidylinositol
  • GlcNAc, N-acetylglucosamine
  • PEA, phosphoethanolamine
  • PI, phosphatidylinositol
  • PNH, paroxysmal nocturnal haemoglobinuria
  • VSG, variant surface glycoprotein

https://doi.org/10.1136/mp.55.3.145

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes